Sorrento Therapeutics
SRNEQ
$0.03000
Share price
3.45%
Change (1 day)
-85.00%
Change (1 year)
Categories
Operating Margin for Sorrento Therapeutics (SRNEQ)
Operating Margin as of May 2024 (TTM): -792.37%
According to Sorrento Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -792.37%. At the end of 2022 the company had an Operating Margin of -893.95%.
Operating Margin history for Sorrento Therapeutics from 2010 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -893.95% | 2.25% |
| 2021 | -874.28% | 12.56% |
| 2020 | -776.72% | -32.1% |
| 2019 | -1,143.98% | 13.41% |
| 2018 | -1,008.73% | -10102.11% |
| 2017 | 10.09% | -101.27% |
| 2016 | -795.30% | 165.29% |
| 2015 | -299.78% | -68.46% |
| 2014 | -950.56% | -80.04% |
| 2013 | -4,761.79% | 473.71% |
| 2012 | -830.00% | 35.46% |
| 2011 | -612.72% | 130.79% |
| 2010 | -265.49% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Karyopharm Therapeutics
KPTI | -90.24% | -88.61% | 🇺🇸 USA |
 Exelixis EXEL | 11.86% | -101.50% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -61.01% | -92.30% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.